Filing Details
- Accession Number:
- 0001209191-13-006902
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2013-02-06 19:29:18
- Reporting Period:
- 2013-02-04
- Filing Date:
- 2013-02-06
- Accepted Time:
- 2013-02-06 19:29:18
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1340652 | Chemocentryx Inc. | CCXI | Pharmaceutical Preparations (2834) | 943254365 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1422996 | C. Juan Jaen | C/O Chemocentryx, Inc. 850 Maude Avenue Mountain View CA 94043 | Svp, Drug Discovery & Cso | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2013-02-04 | 775 | $4.30 | 53,775 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2013-02-04 | 775 | $11.67 | 53,000 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2013-02-04 | 3,100 | $4.30 | 56,100 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2013-02-04 | 3,100 | $11.69 | 53,000 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Employee Stock Option (right to buy) | Disposition | 2013-02-04 | 775 | $0.00 | 775 | $4.30 |
| Common Stock | Employee Stock Option (right to buy) | Disposition | 2013-02-04 | 3,100 | $0.00 | 3,100 | $4.30 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 153,400 | 2017-02-06 | No | 4 | M | Direct | |
| 150,300 | 2017-02-06 | No | 4 | M | Direct |
Footnotes
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
- Reflects the weighted average sale price of the shares sold. The shares were sold in multiple trades at prices ranging from $11.58 to $11.72 per share. The Reporting Person will provide to the SEC staff, the issuer or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price.
- Reflects the weighted average sale price of the shares sold. The shares were sold in multiple trades at prices ranging from $11.65 to $11.73 per share. The Reporting Person will provide to the SEC staff, the issuer or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price.
- As of February 4, 2013 and prior to this transaction, the option fully vested.
- Not applicable.
Billionaire Hedge Funds
